The Role of Rehabilitation Medicine in Managing Cardiopulmonary Complications of Cancer

Syrkin, Grigory; Bartels, Matthew N.

doi:10.1007/s40141-018-0183-z

Cited by 1 publication

(1 citation statement)

References 115 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Doxorubicin (Dox) induced cardiomyopathy accounts for 1.7% to 6.8% in overall prevalence and is much dependent on gross dose (Skubitz et al, 2017). The insidious onset of Dox-induced cardiotoxicity is generally followed by a promptly exaggerated failure of biventricular and sudden death (Syrkin and Bartels, 2018). Doxorubicin induced cardiomyopathy includes characteristic signs and symptoms of any biventricular failure such as cardiomegaly, hepatomegaly, gallop rhythms, ankle oedema, shortness of breath, tachycardia, pleural effusion, distention in neck vein and congestive heart failure (Kelleni andAbdelbasset, 2018, Szmit et al, 2017).…”

Section: Introductionmentioning

confidence: 99%

Untitled

2021

Pak. J. Pharm. Sci

View full text Add to dashboard Cite

The aim of the present study was to evaluate the cardioprotective activity of boswellic acids in doxorubicin (DOX) induced cardiotoxicity. DOX (2.5mg/kg) was used intraperitoneally in rats to induce cardiotoxicity in six divided doses every alternate day over a period of two weeks. Dexrazoxane (10:1) was used as a standard drug. Boswellic acids (250, 500 and 750 mg/kg) were orally administered to rats for 14 days. After 14 days, rats were sacrificed, and blood was withdrawn through cardiac puncture. The blood lipid profile and cardiac biomarkers including LDH, CK-MB, CPK, SGOT and troponin T were measured. The heart of rats was isolated for histopathological studies. Graphpad Prism was used for statistical analysis. There was a significant increase in the level of cardiac enzymes and complete lipid profile parameters in diseased group as compared to control group. Pre-treatment with boswellic acids decreased level of all the measured parameters and decreased the severity of myocardial damage as supported by histopathological studies. It was concluded that boswellic acids possess cardioprotective potential by lowering cardiac biomarkers and blood lipid profile. Thus, boswellic acids might act as cardioprotective agent against doxorubicin induced cardiotoxicity.

show abstract

Section: Introductionmentioning

confidence: 99%

Untitled

2021

Pak. J. Pharm. Sci

View full text Add to dashboard Cite

show abstract

The Role of Rehabilitation Medicine in Managing Cardiopulmonary Complications of Cancer

Cited by 1 publication

References 115 publications

Untitled

Untitled

Contact Info

Product

Resources

About